ENT Devices are used to diagnose and treat disorders related to ear, nose and throat. A Speech Aid is a device which helps in restoring the verbal communication ability of an individual with mild to severe speech impairment. GlobalData uses proprietary data and analytics to provide a comprehensive report on the speech aid devices market in Norway. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the speech aid devices market in Norway was Atos Medical followed by InHealth Technologies, Servona and Hood Laboratories.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Voice Prosthesis and Electrolarynx have been tracked under Speech Aid Devices. A Voice Prosthesis is an artificial device usually made up of medical grade silicone that is placed in an opening on the wall that separates the trachea and esophagus called Tracheoesophageal Puncture that enables a laryngectomized person to speak. An Electrolarynx is a battery operated external electromechanical device that is placed against the neck enabling a laryngectomized person to speak.
The speech aid devices market in Norway can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size speech aid devices in Norway, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
